[ad_1]
The latest IDA guide on infectious and pharmaceutical diseases (Zika Virus Infections – Pipeline Review, 2018) provides an overview of the Zika virus pipeline landscape (Central Nervous System)
. Zika virus infection is caused by a predominantly transmitted virus. by Aedes mosquitoes. The Zika virus is a member of the family Flaviviridae. Symptoms include fever, rash, conjunctivitis, muscle and joint pain, malaise and headache. Risk factors include being in the tropics and subtropics. The Zika virus can be transmitted through sexual intercourse. The treatment aims to relieve symptoms (joint pain and fever) with fluids and medications.
Major Manufacturers:
- Acuitas Therapeutics Inc.
- Bharat Biotech Ltd.
- BioCryst Pharmaceuticals Inc.
- Biotron Ltd.Chugai Pharmaceutical Co. Ltd. [19659005] Cocrystal Pharma Inc.
- Emergent BioSolutions Inc.
- Emergex Vaccines Ltd.
- Ennaid Therapeutics LLC
- Etubics Corp.
- GeneOne Life Science Inc
If you want a copy of the report, feel free to contact @ @ https: // www. industrydataanalytics.com/request-sample-page.php?gturl=zika-virus-infections-pipeline-review-h1-2018-gmd00018?source=thechronicleindia&mode=31 [19659015] ] [1965] 9048] [19659015Anglais]
Highlights of the Report
The Latest Guide to IDA's Product Pipelines Pharmaceuticals and Healthcare (MSA or Shy-Drager Syndrome or Multisystem Degeneration) – Pipeline Review, S1 2018, provides comprehensive information on therapeutic products under development for Zika virus infections (MSA or Shy-Drager or multisystemic degeneration) (central nervous system), with developmental stage analysis, drug target, mechanism of action (MoA), route of administration (RoA) and type of molecule. The guide covers descriptive pharmacological action of therapeutics, its full history of research and development and the latest news and press releases.
The Zika Virus Infections pipeline guide (Infectious Disease) also examines the main players involved in the therapeutic development of Zika virus infections. and presents dormant and abandoned projects. The guide covers the therapies currently being developed by companies / universities / institutes, the molecules developed by companies in phase II, phase I, IND / CTA filed, preclinical, discovery and unknown are respectively 1, 11, 1, 34, 25 and 2. Similarly, the portfolio of Phase II, preclinical and discovery universities includes 2, 11 and 9 respectively.
The Zika Virus Infections pipeline guide (Infectious Disease) helps identify and track emerging market players and their portfolios. decision-making capabilities and helps create effective counter-strategies to gain a competitive advantage. The guide is built from proprietary databases of Global Markets Direct, business / university websites, clinical trial registries, conferences, SEC presentations, investor presentations. and press releases from companies and universities. In addition, various dynamic tracking processes ensure that the latest developments are captured in real time.
A full research report is available https://www.industrydataanalytics.com/zika-virus-infections-pipeline-review-h1-2018-gmd00018-p.php? source = thechronicleindia & mode = 31
Field of application
– The pipeline guide provides an overview of the global therapeutic landscape of Zika virus infections (central nervous system).
– The Pipeline Guide examines therapeutics for Zika Virus (Central Nervous System) infections by companies and universities / research institutes based on information from specific sources at the company and to the industry. from pre-registration to discovery and undisclosed stages.
– The pipeline guide provides descriptive drug profiles for pipeline products that include description, descriptive details of licenses and collaboration, R & D, MdA and other development activities.
– The pipeline guide examines the main companies involved in the Zika virus (central nervous system) therapies and commits all their major and minor projects. – The pipeline guide evaluates Zika virus (central nervous system) therapies based on the mechanism of action, the drug target, the route of administration and the type of molecule.
– Pipeline Guide encapsulates all dormant and abandoned pipelines
– Pipeline Guide Reviews Latest Pipeline Therapy Update for Zika Virus Infections (Central Nervous System)
Discount for this report @ https://www.industrydataanalytics.com/inquire-before-buy.php? gturl = zika-virus-infections-pipeline-review-h1-2018-gmd00018? source = thechronicleindia & mode = 31
Table of Contents
- Introduction
- Zika Virus Infections – Overview 6
- Zika virus infections – Therapeutic development 7
- Zika virus infections – Therapeutic evaluation 20 [19659005] Zika virus infections – Companies involved in therapeutic development 28
- Zika virus infections – Drug profiles 46
- Zika virus infection – Abandoned projects 176
- Zika virus infections – Abandoned products 177 [19659005] Zika virus infections – Product development steps 178
- Appendix 189
Reasons to buy
- Provides information, analysis,
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- To identify and recognize important and varied types of therapies under development for Zika (gastrointestinal) infections.
- Classify New Clients or Potential Partners in the Target
- Plan Tactical Initiatives by Understanding the Areas of Intervention of Large Corporations
- Plan Mergers and Acquisitions Meritoriously by Identifying Key Stakeholders and the most promising pipeline treatments.
- To develop corrective measures for pipeline projects.
- Develop and design sub-licensing and licensing strategies by identifying potential partners with the most attractive projects to enhance and expand the potential and reach of businesses.
- Adjust the therapeutic portfolio by recognizing abandoned projects and understanding from the know-how that led them from the pipeline.
The study was conducted using an objective combination of primary and secondary information, including contributions from key participants in the industry. The report contains a comprehensive landscape of the market and vendors in addition to a SWOT analysis of leading vendors.
About Us:
IndustryDataAnalytics provides syndicated market research reports to industries, organizations or even individuals for the purpose of helping them. decision-making process. MarketInsightsReports is your unique source of market research for all industries, including pharmaceutical, chemical and materials, energy resources, automotive, IT, technology and media, food and beverage and consumer goods, among others.
Contact us for your inquiries We will contact you within 24 hours to help you find the market research report you need.
+1 (704) 266-3234 | mail to: http: // sales @ industrydataanalytics . com
Poster of the publication:
8
Source link
